RE:SPECTRAL MEDICAL ANNOUNCES U.S. FDA APPROVAL OF TIGRIS TRIALI like to accentuate the positive as much as the next guy, but even I am surprised by your misleading stockhouse post headline...
nevertheless further down is the most encouraging bit...
"
we are encouraged by the current mortality results, which exceed expectations.” ...always nice words to hear when you are an investor in a company running a
Confirmatory,
Open Label Trial !
Now lets see how the enrollment rate increases given:
- change to enrollment criteria (25-50% increase in enrollment expected)
- finally 15 sites up and running (another 25 % increase in sites)
- more committed locations (hard to measure the increase from that)
- fewer Covid-19 challenges in the ICU (at least for now)
- mounting real world evidence that PMX-HP may actually help Covid-19 patients who develop endotoxemia/Sepsis.
MM